Site index
Everything, on one page.
172 pages plus 3,234 catalogue products.
14
24
- Services & Solutions
- Drug Product · Clinical Supply
- Candidate Journey
- Oligonucleotide
- Oligonucleotide · Development & Manufacturing
- Oligonucleotide · Development · Analytical
- Oligonucleotide · Development · API
- Oligonucleotide · Development · API · Monomer & Ligand
- Oligonucleotide · Development · Drug Product
- Oligonucleotide · Discovery
- Oligonucleotide · Discovery · Custom Synthesis
- Oligonucleotide · Discovery · Monomer & Ligand
- Oligonucleotide · Discovery · Conjugate
- Peptide
- Peptide · Discovery
- Peptide · Discovery · Custom Synthesis
- Peptide · Discovery · Conjugate
- Peptide · Discovery · Unnatural Amino Acid
- Peptide · Development & Manufacturing
- Peptide · Development · Analytical
- Peptide · Development · API
- Peptide · Development · API · PPMO
- Peptide · Development · Drug Product
- Regulatory Dossier Preparation
10
43
- Lower PMI in Peptide Synthesis: Achievable, Measurable, and Scalable2025-09-02
- Case Study: Enable an Innovative GLP-1 GCG Dual Peptide Program IND filing in Just 10 Months2025-07-23
- Process Development and Large-scale Manufacturing of the Key Northern Fragment of Enlicitide Decanoate2025-07-10
- Case Study: Accelerating Next-Generation Oral Cyclic Peptide from Lead Optimization to GMP Readiness2025-06-17
- Inspiring Hope on Rare Disease Day 2025: Exploring DMD and Next-Generation PMO/PPMO Therapies with WuXi TIDES2025-04-23
- A Comparison of 11-Monomer PNA synthesis2025-01-22
- The Role of Benchmarking Critical Impurity Control in Therapeutic Oligonucleotide Phosphoramidites2024-12-11
- Mastering and Accelerating sgRNA Synthesis: Unveiling Success Strategies2024-10-15
- Case Study: Fast-Track to Phase I: Two siRNA IND CMC Packages Completed in 14 Months2024-07-12
- Case Study: An Integrated Solution to Accelerate a Radionuclide Drug Conjugate to IND2024-05-29
- Forum Video: Accelerated Pharmaceutical Development – Shanghai2024-04-27
- Lipid Nanoparticle (LNP) Platform2024-04-12
- Forum Video: Accelerated Pharmaceutical Development – San Diego2024-04-10
- Expansion Plan Announced during 2024 DCAT Week2024-04-05
- Case Study: Product Focused Solutions for Specialty Oligonucleotide Synthesis2024-03-15
- A case study: An integrated peptide development enables IND submission in 10 months2024-03-08
- Accelerating PPMO Development and Large-scale Manufacturing with Integrated Peptide2024-03-08
- Addressing Oligonucleotide Development Challenges from a CRDMO’s Perspective2024-03-08
- Case Study: Accelerate Commercial Manufacturing of an Oligonucleotide with WuXi Speed2024-03-08
- Case Study: An siRNA Drug Product IND Filing Ready in 10 Months2024-03-08
- Case Study: IND Ready in 11 Months for a PPMO Drug Candidate2024-03-08
- Case Study: PDC Drug R&D and Manufacturing in 9 Months2024-03-08
- Webinar: Challenges and Opportunities in Peptide Drug Conjugates (PDCs)2024-03-08
- DNA G-Quadruplexes kilo-Grams Scale Production with Controlled Heavy Metal Strategy2024-03-08
- Oligonucleotide Facility Virtual Tour2024-03-08
- Middletown Campus Groundbreaking Ceremony (Delaware, USA)2024-03-08
- Middletown Campus Topping Off Ceremony (Delaware, USA)2024-03-08
- Middletown, Delaware Site Updates by Site Head2024-03-08
- Oligonucleotide CRDMO Chemistry Platform2024-03-08
- Oligonucleotide Drug Development (CMC)2024-03-08
- Oligonucleotide Drug Discovery2024-03-08
- Peptide API & Drug Product Facility Virtual Tour2024-03-08
- Peptide CRDMO Chemistry Platform2024-03-08
- Empowering Highly Potent Peptide Drug Conjugate Scale-up with Flow Chemistry2024-03-08
- Streamline the import and export of drug substance and drug product between China and the US2024-03-08
- Trends in Oligonucleotide Drug Development – a Virtual Panel Discussion2024-03-08
- How Does It Work? Peptide Oligonucleotide Conjugate2024-03-08
- Accelerating Novel Peptides into Clinical Trials with Integrated Partnership2024-03-08
- Novel Peptide Hit Identifcation and Lead Generating Strategies for Drug Discovery2024-03-08
- White book: Absorption prediction tools for drug formulation at the preclinical stage white paper2024-03-08
- Peptide Therapeutics CDMO Partner2024-03-08
- Picking the Right CDMO Partner for Integrated and Accelerated Peptide Therapeutic Development2024-03-08
- Forum Video: Accelerated Pharmaceutical Development – Boston2023-12-13
63
- WuXi AppTec’s Changzhou and Taixing API Sites Successfully Pass FDA Inspections2025-04-01
- WuXi AppTec’s Couvet Site Receives EcoVadis 2024 Silver Medal Rating2024-11-18
- WuXi AppTec Opens New R&D Center in Changzhou, China2024-11-14
- WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers2024-05-23
- A Successful PAI for a new Peptide Drug from Japan PMDA2024-04-09
- 2024 CDMO Leadership Awards2024-03-21
- WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site2024-01-08
- WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site2023-07-17
- WuXi STA Forms Strategic Partnership with Ark Biopharmaceutical for the Commercial Supply of Ziresovir2023-05-23
- WuXi TIDES Adds New Peptide Manufacturing Capacity and Large-Scale Continuous Purification System2023-04-05
- An invitation to the WuXi TIDES forum in London2023-03-16
- WuXi STA Receives 2023 CDMO Leadership Award in Recognition of Capabilities and Reliabilities2023-02-24
- WuXi STA Launches First Continuous Manufacturing Line for Oral Solids2023-01-03
- Three Sites from WuXi STA Receive Top EcoVadis Scores for Business Sustainability Rating2022-12-13
- WuXi STA and Multiply Labs announce partnership and successfully deploy robotic manufacturing system for personalized drugs2022-12-01
- WuXi STA Launches Another Parenteral Formulation Manufacturing Line at Wuxi City Site2022-11-30
- WuXi STA Successfully Passes Four Pre-Approval Inspections by South Korea’s Ministry of Food and Drug Safety at Three Manufacturing Sites in China2022-10-12
- WuXi STA Opens a New Clinical Supply Service Facility at Shanghai Waigaoqiao Site2022-09-30
- WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility2022-09-26
- WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers2022-09-09
- WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware2022-08-16
- WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation2022-07-19
- WuXi STA Opens a New Large Scale Continuous Manufacturing Plant at Changzhou Site2022-07-15
- WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility2022-07-07
- WuXi STA Opens Another High-Potency API Plant in Changzhou, China2022-06-24
- Expansion Plan Announced at DCAT Including Oligonucleotide2022-03-21
- WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site2022-03-03
- WuXi STA and Hua Medicine Sign Supply Agreement for Dorzagliatin2022-02-21
- WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories2022-02-08
- WuXi STA Launches its First Parenteral Formulation Manufacturing Line2022-01-21
- WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao Site2022-01-04
- WuXi STA Received 2020 CDMO Award from Roche2021-12-23
- WuXi STA Forms Strategic Partnership with Xynomic Pharma2021-12-16
- WuXi STA Forms Strategic Partnership with Coherent Biopharma2021-11-22
- Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT2021-11-08
- WuXi STA Completes Acquisition of Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland2021-08-03
- WuXi STA Forms Strategic Partnership with BioNova2021-07-21
- WuXi STA Forms Strategic Partnership with InnoCare2021-07-16
- WuXi STA Chooses Middletown Delaware for New Pharmaceutical Manufacturing Campus2021-06-28
- WuXi STA Forms Strategic Partnership with Ascentage Pharma2021-06-03
- WuXi STA Opens New Drug Product Facility in Wuxi City Site2021-05-20
- WuXi STA and WuXi Biologics Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services2021-05-14
- WuXi STA Starts Construction of New Site in Taixing China2021-04-28
- Three WuXi STA Facilities Pass Pre-Approval Inspection From NMPA2021-04-12
- WuXi STA Forms Strategic Partnership with AnHeart to Accelerate the Development of Novel Oncology Therapies2021-03-15
- 2021, WuXi STA Again Wins CMO Leadership Awards in All Six Core Categories2021-02-25
- WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland2021-02-02
- WuXi STA, WuXi Biologics and Antengene Announce Collaboration to Advance Antibody-Drug Conjugate Candidate into Clinical Stage2021-02-01
- WuXi STA’s Integrated CMC Platform Supports InnoCare’s Orelabrutinib Approved by NMPA2020-12-25
- Tubulis Forms Strategic Partnership with WuXi STA and WuXi Biologics to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation2020-12-02
- WuXi STA Forms Strategic Partnership with BeiGene2020-06-05
- WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility2020-01-02
- WuXi STA Forms Strategic Partnership with Impact Therapeutics2019-11-20
- WuXi STA Forms Strategic Partnership with Impact Therapeutics2019-11-18
- Dr. Ge Li Awarded “CEO of the Year” at CPhI Worldwide 20192019-11-12
- Dr. Ge Li Awarded “CEO of the Year” at CPhI Worldwide 20192019-11-11
- WuXi STA’s Jinshan Facility Passes EMA Inspection2019-10-28
- WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections2019-07-23
- WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement2019-05-22
- WuXi STA’s New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection2019-03-27
- WuXi STA Forms Strategic Partnership with Beta Pharma2019-03-22
- WuXi STA and Ark Biosciences Sign CMC Development and Manufacturing Agreement2019-03-06
- WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery2019-02-19
3,234
Every catalogue product has its own page. They are indexed for search and listed in sitemap.xml; browse them by family, category, stock or price.
How can we help?
Our TIDES drug experts stand ready.
Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.
Small molecule projects? WuXi STA